Bavarian Nordic Ramps Up Mpox Vaccine Production Amid Africa CDC's Public Health Emergency Declaration

Bavarian Nordic A/S (OMX: BAVA) provides an update on plans for securing supply of vaccines to tackle the current mpox outbreak that the Africa Centers f...

August 19, 2024 | Monday | News
Fapon Biotech Strengthens Global Response to Monkeypox with Innovative Antigen Diagnostics

  Fapon Biotech is a global leader in the In-vitro Diagnostics (IVD) industry, with a steadfast commitment to advancing global health by providing in...

August 19, 2024 | Monday | News
Eisai and Biogen Announce Middle East Approval of Alzheimer’s Drug LEQEMBI® (lecanemab) in the UAE

Eisai Co., Ltd. and Biogen Inc. are pleased to announce that the Ministry of Health and Prevention in the United Arab Emirates (UAE) has approved the hum...

August 15, 2024 | Thursday | News
HERA and Bavarian Nordic to Deliver 215,000 Doses of Mpox Vaccine to Africa Amidst Rapid Outbreak

HERA will procure 175,420 doses for immediate response to the concerning mpox outbreak in Africa, and furthermore, Bavarian Nordic will donate 40,000 d...

August 14, 2024 | Wednesday | News
Kyowa Kirin International Partners with NewBridge Pharmaceuticals to Distribute Rare Disease Treatments in Middle East and North Africa

Agreement will see NewBridge Pharmaceuticals act as a multi-country distributor in four countries across the Middle East and North Africa (MENA) ...

August 07, 2024 | Wednesday | News
Teva Pharmaceuticals’ AJOVY Achieves Primary End Point in Pediatric Phase 3 Migraine Study

SPACE pediatric Phase 3 study met its primary end point for efficacy with a significantly greater reduction in Monthly Migraine Days compared to ...

July 19, 2024 | Friday | News
Eisai and Biogen Announce Approval of Alzheimer’s Treatment LEQEMBI® in Israel

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher...

July 12, 2024 | Friday | News
Twist Bioscience Expands High-Throughput Antibody Portfolio with Launch of CHO Cell Line for Faster Turnaround Times

Express Genes enable faster turnaround times Twist Express Antibodies, CHO starting at 13 business days Twist Express Antibodies, HEK293 starti...

July 11, 2024 | Thursday | News
Pfizer Celebrates 175 Years of Innovation and Global Healthcare Leadership

Landmark event marks Pfizer's enduring legacy, innovative achievements and commitment to help shaping the future of global healthcare By leveraging AI...

June 12, 2024 | Wednesday | News
Abu Dhabi Signs Landmark MoU with ADIO, Etihad Airways, and AD Ports Group to Become Global Pharma and Life Sciences Hub

BIO International Convention 2024, The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, and Abu Dhabi...

June 10, 2024 | Monday | News
Bio-Sourcing and Afrigen Biologics Forge Partnership to Advance Biotherapeutics in South Africa

Technology transfer will strengthen South Africa’s pharmaceutical sovereignty and drastically reduce production costs, thus improving affordability...

June 05, 2024 | Wednesday | News
BioNTech and CEPI Partner to Enhance mRNA Vaccine Production in Africa

BioNTech and CEPI aim to enhance local R&D, clinical and commercial-scale manufacturing capacities to develop potential mRNA vaccines in Africa, fo...

May 30, 2024 | Thursday | News
lifespin GmbH and Acıbadem University Forge Global Alliance to Spearhead Precision Medicine Revolution

lifespin GmbH, a pioneer in health status detection software, has teamed up with Acıbadem University (ACU) and Acıbadem Healthcare Group (AHG) to launc...

May 28, 2024 | Tuesday | News
Biomerica and UAE's Healthcare Giant Ink Pioneering Deal for Advanced Cancer Screening Technologies

Biomerica Inc. , a global leader in innovative medical diagnostics, proudly announces a landmark multi-year exclusive distribution agreement with one of th...

April 30, 2024 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close